Anti-CCP antibodies have more diagnostic impact than rheumatoid factor (RF) in a population tested for RF (Q56785749)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410320%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

Anti-CCP antibodies have more diagnostic impact than rheumatoid factor (RF) in a population tested for RF (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410320%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

0 references

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410320%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

I G Silveira

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410320%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

R W Burlingame

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410320%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

C A von Mühlen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410320%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

H L Staub

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410320%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

language of work or name

English

0 references

publication date

5 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410320%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

published in

Clinical Rheumatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410320%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410320%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410320%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

1883-1889

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410320%20AND%20SRC:MED&resulttype=core&format=json

Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies

28 December 2019

cites work

1 reference

12 December 2020

Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases

1 reference

12 December 2020

Anti-cyclic citrullinated antibodies: complementary to IgM rheumatoid factor in the early diagnosis of rheumatoid arthritis.

1 reference

12 December 2020

The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis

1 reference

12 December 2020

The likelihood ratio. An improved measure for reporting and evaluating diagnostic test results

1 reference

12 December 2020

The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis

1 reference

12 December 2020

Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations

1 reference

12 December 2020

Second generation anti-cyclic citrullinated peptide (anti-CCP2) antibodies can replace other anti-filaggrin antibodies and improve rheumatoid arthritis diagnosis

1 reference

12 December 2020

Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis

1 reference

12 December 2020

Diagnostic tests for rheumatoid arthritis: comparison of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factors

1 reference

12 December 2020

The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide

1 reference

12 December 2020

Anti-keratin antibodies in rheumatoid arthritis

1 reference

12 December 2020

Diagnosing early rheumatoid arthritis (RA). What are the problems and opportunities?

1 reference

12 December 2020

Joint erosions and patients with early rheumatoid arthritis

1 reference

12 December 2020

Imaging in early rheumatoid arthritis: roles of magnetic resonance imaging, ultrasonography, conventional radiography and computed tomography

1 reference

12 December 2020

Treating rheumatoid arthritis early: a window of opportunity?

1 reference

12 December 2020

Diagnostic tests 4: likelihood ratios

1 reference

12 December 2020

A NEW SERUM FACTOR IN PATIENTS WITH RHEUMATOID ARTHRITIS; THE ANTIPERINUCLEAR FACTOR.

1 reference

12 December 2020

Clinical utility of likelihood ratios.

1 reference

12 December 2020

The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies

1 reference

12 December 2020

Identification of citrullinated rheumatoid arthritis-specific epitopes in natural filaggrin relevant for antifilaggrin autoantibody detection by line immunoassay

1 reference

12 December 2020

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

12 December 2020

The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues

1 reference

12 December 2020

Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression

1 reference

12 December 2020

A comparison of IgM rheumatoid factor by nephelometry and latex methods: clinical and laboratory significance

1 reference

12 December 2020

Test research versus diagnostic research

1 reference

12 December 2020

Clinical utility of the anti-CCP assay: experiences with 700 patients

1 reference

12 December 2020

Autoantibodies to filaggrin/deiminated fibrin (AFA) are useful for the diagnosis and prognosis of rheumatoid arthritis, and are probably involved in the pathophysiology of the disease

1 reference

12 December 2020

Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis

1 reference

12 December 2020

The latex test revisited. Rheumatoid factor testing in 8,287 rheumatic disease patients

1 reference

12 December 2020

Diagnostic and prognostic characteristics of the enzyme linked immunosorbent rheumatoid factor assays in rheumatoid arthritis

1 reference

12 December 2020

Nephelometry compared with differential antibody titre in routine rheumatoid factor measurements

1 reference

12 December 2020

Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset

1 reference

12 December 2020

10.1007/S10067-007-0601-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410320%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference